E42: China's tech crackdown, CRISPR breakthro...
Up next
Recommended Episodes
The EU drug regulator will launch an investigation next week into whether clinical trials of Russia’s Sputnik V Covid-19 vaccine contravened ethical standards, and Japan’s national champion, Renesas Electronics, is being forced to diversify due to the pressures brought on by t ...
Canberra is contemplating investing in a A$1bn biopharmaceutical plant to reduce its dependence on imports of critical medicines, China’s state-backed pharmaceutical group, Sinopharm, wants more governments to buy its Covid-19 vaccine, and Spain is set to become the first EU c ...
Positive results from the first US Covid-19 trial raised investors’ hopes of an economic rebound, Chinese self-driving car start-ups have been accelerating pilot projects as US rivals sit idle, and bond investors have hit out at the growing trend of companies reporting “earnin ...